Top Stories

Top Stories

FDA approves first gene therapy for genetic hearing loss

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The drugmaker said it will offer the drug for free to U.S. patients. Otarmeni is approved to …

Read More »
The Ultimate Managed Hosting Platform